Skip to content

Observation on therapeutic effect of Qingjie Jie Re granule on children influenza

Observation on therapeutic effect of Qingjie Jie Re granule on children influenza

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005693
Enrollment
Unknown
Registered
2022-03-11
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

Experimental group:Oseltamivir phosphate granules + antipyretic granules
The control group:Oseltamivir phosphate granules

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Meet the western diagnostic criteria for influenza; 2. Out-patient children with the course of disease within 48 hours; 3. Conforming to the syndrome differentiation standard of TCM wind-heat syndrome; 4. Aged from 3 to 12; 5. The informed consent process is in accordance with the provisions, and the legal representative or the subject child (=8 years old) jointly signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe or critical cases of influenza; 2. Antiviral drugs were used within 48 hours before this visit; 3. Children with chronic and serious underlying diseases; 4. Children with intolerance to study drugs; 5. The researcher thinks that the person is not suitable to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Adverse events/reactions occurred during treatment were recorded;CARIFS symptom dimension score and its area under the curve relative to time;Disappearance rate of single symptom;Hospitalization rates;Use rate of antifebrile drugs;Vital signs (temperature, respiration, heart rate, blood pressure), blood routine, urine routine, ELECTROcardiogram, liver function (ALT, AST, ALP), kidney function (BUN, Cr);Curative effect of TCM syndromes (cure rate);Influenza virus nucleic acid negative conversion rate;Time of antipyretic effect;Time for complete fever reduction;Duration of immediate fever reduction;

Countries

China

Contacts

Public ContactJianshe Wang
jshwang@shmu.edu.cn18017590987

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026